Moreover, in breast cancer cells PKCζ physically and functionally binds to Akt, resulting in the inhibition of Akt phosphorylation at both Thr308 and Ser473, and leading to a decrease in Akt activity that limits signaling coupled to PI3K/Akt pathway63. Here, AKT1 is linked to breast carcinoma.